Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens

September 11, 2020 updated by: Bausch & Lomb Incorporated

The Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens

This will be a randomized non-dispensing study comparing the overnight corneal swelling of an eye while wearing no contact lens to the Ultra contract lens.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Bloomington, Indiana, United States, 47405
        • Indiana University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be between 18 and 40 years of age (inclusive)
  • Not a current contact lens wearer (have not worn extended wear, and not worn in lenses in 6 months)
  • Able to read, comprehend and sign an informed consent
  • Willing to comply with the wear and study visit schedule
  • Monocular best-corrected distance visual acuity >/-20/25 in each eye

Exclusion Criteria:

  • Any active corneal infection, disease, injury, inflammation, past surgery, or ocular abnormality which may interfere with contact lens wear
  • Systemic or ocular allergies, which might interfere with contact lens wear
  • Systemic disease or condition, which might interfere with contact lens wear
  • Use of prescription sleep aids or alcohol within 24 hours of study appointment
  • Inability to wear contact lenses
  • Under 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study Group 1
1st overnight visit with no contact lens; 2nd overnight visit randomized to either left or right eye for B&L Investigational Contact Lens
The lens used in this study will be supplied by the Sponsor. All subjects will wear a -3.00D lens.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent Change in Central Corneal Thickness
Time Frame: 8 hours
Percent change in central corneal thickness from evening to morning (after 8 hours with lid closed)
8 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Restore Central Corneal Thickness
Time Frame: 48 hours
Time (hours) to restore central corneal thickness to its baseline value after lens removal
48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Robert Steffen, OD, MS, Bausch & Lomb Incorporated

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 3, 2014

Primary Completion (Actual)

December 11, 2014

Study Completion (Actual)

December 11, 2014

Study Registration Dates

First Submitted

October 3, 2014

First Submitted That Met QC Criteria

October 6, 2014

First Posted (Estimate)

October 7, 2014

Study Record Updates

Last Update Posted (Actual)

September 14, 2020

Last Update Submitted That Met QC Criteria

September 11, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 14-002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Corneal Deformity

Clinical Trials on B&L Investigational Contact Lens

Subscribe